FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP Read more about FDA Approves Nplate(TM) for Long-Term Treatment of Adult Chronic ITP
Amgen Licenses Molecule for the Treatment of Chronic and Neuropathic Pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc. Read more about Amgen Licenses Molecule for the Treatment of Chronic and Neuropathic Pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA Today Read more about Amgen Issues Statement in Response to Revised ESA Labeling Received from the FDA Today
Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14 Read more about Amgen's Second Quarter 2008 Adjusted Earnings Per Share Increased 2 Percent to $1.14
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial Read more about Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial
250 Amgen Scholars from 10 Premier Universities Convene for National Summer Symposium to Explore Drug Discovery & Development Read more about 250 Amgen Scholars from 10 Premier Universities Convene for National Summer Symposium to Explore Drug Discovery & Development
Amgen Announces Webcast of 2008 Second Quarter Financial Results Read more about Amgen Announces Webcast of 2008 Second Quarter Financial Results
Study Showed Half of Patients Treated with Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had No Progression of Joint Damage in Active Early Rheumatoid Arthritis Read more about Study Showed Half of Patients Treated with Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had No Progression of Joint Damage in Active Early Rheumatoid Arthritis
Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy Read more about Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
Amgen and Ortho Biotech Settle Antitrust Suit Read more about Amgen and Ortho Biotech Settle Antitrust Suit
